Exact Sciences Corp
Ouvert
SecteurSoins de santé
104.93
Résumé
Variation du prix de l'action
24h
Min
104.9
Max
104.96
Revenu | -66M -86M |
|---|---|
Ventes | 28M 878M |
BPA | -0.21 |
Marge bénéficiaire | -9.786 |
Employés | 7,100 |
EBITDA | -68M -20M |
Recommandations | Neutre |
|---|---|
Prévisions sur 12 Mois | +0.09% upside |
Capitalisation Boursière | 404M 20B |
|---|---|
Ouverture précédente | 104.93 |
Clôture précédente | 104.93 |
Score Technique
By Trading Central
Confiance
Strong Bullish Evidence
Exact Sciences Corp Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
Actualités Associées
Comparaison
Variation de prix
Exact Sciences Corp prévision
Objectif de Prix
By TipRanks
0.09% hausse
Prévisions sur 12 Mois
Moyen 105 USD 0.09%
Haut 105 USD
Bas 105 USD
Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.
Éléments financiers
$
À Propos Exact Sciences Corp
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
